The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern.
The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern.
复制标题
角蛋白单克隆抗体在人类表皮疾病中的应用:免疫组织化学染色模式的改变。
DOI:
10.1111/1523-1747.ep12518198
复制
发表时间:
1983
期刊:
影响因子:
--
通讯作者:
Sun,TT
中科院分区:
文献类型:
--
作者:
Weiss,RA;Guillet,GY;Freedberg,IM;Farmer,ER;Small,EA;Weiss,MM;Sun,TT
A monoclonal antikeratin antibody, designated AE1, was used to stain frozen sections of normal and abnormal human skin by the immunofluorescence and peroxidase-antiperoxidase techniques. In normal human epidermis and ichthyosis vulgaris, a nonproliferative epidermal disease, this antibody selectively stained epidermal basal cells. Very different staining patterns were observed in various other epidermal diseases. A suprabasal staining pattern was observed in psoriasis (16 cases), verruca (9), seborrheic keratosis (5), actinic keratosis (2), as well as the epidermis adjacent to certain epidermal neoplasms (4). Basal cell carcinoma (7) showed weak, homogeneous staining. In contrast, a disorganized pattern consisting of cells with various staining intensities was observed in Bowen's disease (2) and squamous cell carcinoma (4). Although the biochemical basis for these altered staining patterns remains to be elucidated, these results provide further evidence that epidermal keratin expression can be affected by various disease states. Moreover, our data suggest that a common alteration in keratin expression, as defined by the suprabasal AE1 staining pattern, exists in psoriasis and a number of other benign hyperproliferative epidermal diseases.